Startups
Asgard Therapeutics

Asgard Therapeutics

https://asgardthx.com

Developer of vivo direct cell reprogramming for cancer immunotherapy.

Summary

Seedtable Score
  • 46
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Series A
Industry

Total funding Amount

$37M

Fundraising History

  • Mar 14 '24 Series A
    $30M
  • Nov 01 '21 Seed
    $6.9M

Investors

  • Novo A/S
    Series A
  • Johnson & Johnson
    Series A
  • Boehringer Ingelheim Venture Fund
    Series A
  • Industrifonden
    Seed